Biotage® Sfär C18 D - Duo 100 Å 30 μm has been developed for reversed phase flash chromatography, a very effective purification technique for polar, ionizable and highly lipophilic compounds which cannot easily be separated by normal phase techniques.
Biotage® Sfär C18 D is the column of choice when you want to increase efficiency and speed in your reverse phase separations while having the flexibility in the way you load your sample thanks to the accessible columns.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
FSUD-0401-0012 | Biotage® Sfär C18 D Duo 100 Å 30 µm 12 g | 2 | 156 USD | Add to quote/cart |
FSUD-0401-0120 | Biotage® Sfär C18 D Duo 100 Å 30 µm 120 g | 2 | 800 USD | Add to quote/cart |
FSUD-0401-0240 | Biotage® Sfär C18 D Duo 100 Å 30 µm 240 g | 1 | 1128 USD | Add to quote/cart |
FSUD-0401-0030 | Biotage® Sfär C18 D Duo 100 Å 30 µm 30 g | 2 | 359 USD | Add to quote/cart |
FSUD-0401-0400 | Biotage® Sfär C18 D Duo 100 Å 30 µm 400 g | 1 | 1352 USD | Add to quote/cart |
FSUD-0401-0006 | Biotage® Sfär C18 D Duo 100 Å 30 µm 6 g | 2 | 112 USD | Add to quote/cart |
FSUD-0401-0060 | Biotage® Sfär C18 D Duo 100 Å 30 µm 60 g | 2 | 479 USD | Add to quote/cart |
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs appr. 700 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage